ResearcherMashhad University of Medical SciencesNo recent work listed
Safieh Ebrahimi
Matched on ORCID iD 0000-0003-2135-867X; OpenAlex author ID A5040539767. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2016: 1 paper · 2017: 1 paper
Papers 2
- Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer. Co-author DOI 10.2174/0929867324666170206142658↗
- Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer. Co-author DOI 10.2174/1381612822666160817095047↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mina Hosseini · 2 shared papers, 2016–2017 · strength 0.13
- Paper Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer. DOI 10.2174/0929867324666170206142658↗
- Paper Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer. DOI 10.2174/1381612822666160817095047↗
- Mina Maftouh · 2 shared papers, 2016–2017 · strength 0.13
- Paper Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer. DOI 10.2174/0929867324666170206142658↗
- Paper Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer. DOI 10.2174/1381612822666160817095047↗
- Amir Avan · 2 shared papers, 2016–2017 · strength 0.13
- Paper Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer. DOI 10.2174/0929867324666170206142658↗
- Paper Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer. DOI 10.2174/1381612822666160817095047↗
- Gordon A. Ferns · 1 shared paper, 2017 · strength 0.07
- Majid Ghayour‐Mobarhan · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.